An Important Notice from OMRON Healthcare, Inc. We have recently become aware of online scammers selling counterfeit products that appear to be from OMRON, but they are not legitimate. These fraudulent products can pose risks to your health and may not deliver the quality or performance you expect from OMRON. To protect yourself, please ensure you are purchasing OMRON products only from reputable, authorized resellers. Your health and safety are our top priority, and we are committed to providing you with trusted, high-quality products that meet the highest clinical standards of accuracy.
Heart health leader OMRON Healthcare today issued an urgent health message across the U.S. to raise public awareness of rapidly increasing risks and rising mortality rates associated with arrythmias such as atrial fibrillation (AFib), heart failure, and heart disease from long-term high blood pressure, as identified in new research.
Number one doctor and pharmacist-recommended blood pressure monitor brand introduces blood pressure monitors with OMRON Intellisense™ AFib
Intellisense AFib Technology Able to Detect Possible Atrial Fibrillation with Every Measurement; May 17 Marks World Hypertension Day during May Measurement Month
Meet the innovators using home monitoring devices to reshape cardiac care—making early detection more accessible than ever.
Advancing its Going for Zero mission, OMRON innovation makes AFib screening an integral part of the brand’s routine home blood pressure monitoring experience
Ms. Koehler succeeds Ranndy Kellogg, takes the helm of the U.S. and Canada’s leading brand of personal heart health products and wellness technologies